JP Morgan Chase’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
JP Morgan Chase's NXTC Position: Q3 2026 in Review
JP Morgan Chase increased its NextCure (NXTC) stake by 121,887% in Q3 2026, buying an estimated $414K and bringing the position to 74,412 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #5427.
JP Morgan Chase first reported a position in NXTC in Q2 2019 and has held it in 30 quarters since. The position peaked at $1.09M in Q3 2020. 29 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.
- JP Morgan Chase held 74,412 shares of NextCure worth $361K as of Q3 2026.
- JP Morgan Chase bought 74,351 NextCure shares in Q3 2026, an estimated $414K.
- NextCure made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5427 holding.
- JP Morgan Chase first reported a position in NextCure in Q2 2019 and has held it in 30 quarters since.
- JP Morgan Chase's NextCure position peaked at $1.09M in Q3 2020.
- 29 funds tracked by Wall St. Rank held NextCure as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.